First human trial: radiation pellets supercharge cancer immunotherapy
NCT ID NCT04620603
Summary
This early study is testing whether adding tiny radioactive pellets directly into tumors can boost the effectiveness of standard immunotherapy drugs. The trial involves just 5 patients with advanced melanoma, kidney cancer, or bladder cancer that has spread. Researchers want to see if this combination is safe and whether it helps shrink tumors better than immunotherapy alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic, Case Comprehensive Cancer Center
Cleveland, Ohio, 44122, United States
Conditions
Explore the condition pages connected to this study.